Chromocell Therapeutics Stock Price on January 15, 2025
| CHRO Stock | USD 1.80 0.38 17.43% |
If you're considering investing in Chromocell Stock, it is important to understand the factors that can impact its price. As of today, the current price of Chromocell Therapeutics stands at 1.80, as last reported on the 10th of March, with the highest price reaching 2.12 and the lowest price hitting 1.80 during the day. Chromocell Therapeutics is extremely dangerous given 3 months investment horizon. Chromocell Therapeutics secures Sharpe Ratio (or Efficiency) of 0.19, which signifies that the company had a 0.19 % return per unit of risk over the last 3 months. We were able to interpolate data for twenty-eight different technical indicators, which can help you to evaluate if expected returns of 3.05% are justified by taking the suggested risk. Use Chromocell Therapeutics Downside Deviation of 9.4, mean deviation of 8.94, and Risk Adjusted Performance of 0.1542 to evaluate company specific risk that cannot be diversified away.
At this time, Chromocell Therapeutics' Capital Stock is very stable compared to the past year. As of the 10th of March 2025, Stock Based Compensation is likely to grow to about 4.8 M, while Total Stockholder Equity is likely to drop (6.1 M). . As of the 10th of March 2025, Price To Sales Ratio is likely to drop to 110.78. In addition to that, Price Earnings Ratio is likely to drop to -3.54. Chromocell Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Chromocell |
Sharpe Ratio = 0.1916
| Best Portfolio | Best Equity | |||
| Good Returns | CHRO | |||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 15.95 actual daily | 96 96% of assets are less volatile |
Expected Return
| 3.05 actual daily | 60 60% of assets have lower returns |
Risk-Adjusted Return
| 0.19 actual daily | 15 85% of assets perform better |
Based on monthly moving average Chromocell Therapeutics is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Chromocell Therapeutics by adding it to a well-diversified portfolio.
Related Headline
Skillful Craftsman Headline on 15th of January 2025
Skillful Craftsman Education Reports Financial Results for H... by news.google.com
Skillful Craftsman Education Reports Financial Results for H1 2024 TipRanks
Chromocell Therapeutics Valuation on January 15, 2025
It is possible to determine the worth of Chromocell Therapeutics on a given historical date. On January 15, 2025 Chromocell was worth 0.93 at the beginning of the trading date compared to the closed value of 0.97. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Chromocell Therapeutics stock. Still, in general, we apply an absolute valuation method to find Chromocell Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Chromocell Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Chromocell Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 0.90 | 1.05 | 0.87 | 0.94 | 12,900 | |
01/15/2025 | 0.93 | 1.04 | 0.91 | 0.97 | 25,100 |
| 0.99 | 1.45 | 0.81 | 0.96 | 618,000 |
| Backtest Chromocell Therapeutics | | | Chromocell Therapeutics History | | | Chromocell Therapeutics Valuation | Previous | Next |
Chromocell Therapeutics Trading Date Momentum on January 15, 2025
| On January 16 2025 Chromocell Therapeutics was traded for 0.96 at the closing time. The top price for the day was 1.45 and the lowest listed price was 0.81 . The trading volume for the day was 618 K. The trading history from January 16, 2025 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 1.03% . The overall trading delta against the current closing price is 146.39% . |
Chromocell Therapeutics Fundamentals Correlations and Trends
By evaluating Chromocell Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Chromocell Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Chromocell financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Chromocell Therapeutics Stock history
Chromocell Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Chromocell is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Chromocell Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Chromocell Therapeutics stock prices may prove useful in developing a viable investing in Chromocell Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 5.2 M | 4.6 M |
Chromocell Therapeutics Stock Technical Analysis
Chromocell Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Chromocell Therapeutics Period Price Range
Low | March 10, 2025
| High |
0.00 | 0.00 |
Chromocell Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NYSE MKT Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Chromocell Therapeutics March 10, 2025 Market Strength
Market strength indicators help investors to evaluate how Chromocell Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Chromocell Therapeutics shares will generate the highest return on investment. By undertsting and applying Chromocell Therapeutics stock market strength indicators, traders can identify Chromocell Therapeutics entry and exit signals to maximize returns
Chromocell Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Chromocell Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Chromocell Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Chromocell to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1542 | |||
| Jensen Alpha | 3.18 | |||
| Total Risk Alpha | 4.38 | |||
| Sortino Ratio | 0.3144 | |||
| Treynor Ratio | 0.7222 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chromocell Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Chromocell Stock, please use our How to Invest in Chromocell Therapeutics guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chromocell Therapeutics. If investors know Chromocell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chromocell Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Chromocell Therapeutics is measured differently than its book value, which is the value of Chromocell that is recorded on the company's balance sheet. Investors also form their own opinion of Chromocell Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Chromocell Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chromocell Therapeutics' market value can be influenced by many factors that don't directly affect Chromocell Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chromocell Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Chromocell Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chromocell Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.